GLP-1s can help employers lower medical costs in 2 years: study
GLP-1 Drugs: Transforming Healthcare Costs and Outcomes for Employers The increasing demand for diabetes and weight loss medications, specifically GLP-1s like Mounjaro, Ozempic, and Wegovy, has significantly influenced healthcare costs. These drugs, priced at over $1,000 per dose, present both a financial challenge and an opportunity for employers seeking to improve their workforce health and … Read more